Orion's Capital Markets Day on Wednesday 22 May 2019.
Orion published its Interim Report for January-March 2019 on Thursday, 25 April 2019.
Published on 4 March 2019 I The Financial Statement documents 2018 include the Financial Statements, the Report of the Board of Directors and the Auditor’s Report.
8 Mar 2019 I Marketing authorization application has been submitted to EMA. The rolling submission to the FDA in the U.S. was recently completed and the application has also been submitted in the MHLW in Japan.
6 Feb 2019 I Financial Statement Release for 2018 and related materials now published.
The 2019 Annual General Meeting was held on 26 March 2019 in Helsinki. Read more here.
Updated on 15 March 2019.
Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.
Monthly updated list of Orion's major shareholders by votes.
Orion's key research projects include three ongoing Phase III trials, among others.
Orion Corporation has been included in the globally recognised FTSE4Good Index.
